Thiazolidine derivatives
    3.
    发明授权
    Thiazolidine derivatives 失效
    噻唑烷衍生物

    公开(公告)号:US4125614A

    公开(公告)日:1978-11-14

    申请号:US788905

    申请日:1977-04-19

    CPC classification number: C07D417/12 C07D277/18 Y10S514/869

    Abstract: The invention relates to thiazolidine derivatives having in 4-position a hydroxy group and a 3'-sulphamyl-phenyl substituent, in 2-position an imino group and in 1-position an aliphatic or cycloaliphatic substituent. Said thiazolidines have diuretic activity.The invention also relates to a process for the manufacture of said compounds.

    Abstract translation: 本发明涉及具有4位羟基和3'-磺酰氨基 - 苯基取代基的噻唑烷衍生物,2-位亚氨基和1-位脂肪族或脂环族取代基。 所述噻唑烷具有利尿活性。

    Thiazolidine derivatives
    4.
    发明授权
    Thiazolidine derivatives 失效
    噻唑烷衍生物

    公开(公告)号:US4061647A

    公开(公告)日:1977-12-06

    申请号:US709075

    申请日:1976-07-27

    CPC classification number: C07D513/04 C07C309/00 C07D277/18 Y10S514/869

    Abstract: The invention relates to thiazolidine derivatives having in 4-position a hydroxy group and a 3'-sulphamyl-phenyl substituent the phenyl ring of which is di-substituted by halogen or methyl, in 2 position an imino group and in 1-position an aliphatic or cycloaliphatic substituent. Said thiazolidines have diuretic activity.The invention also relates to a process for the manufacture of said compounds.

    Abstract translation: 本发明涉及具有4-位羟基的噻唑烷衍生物和苯基环被卤素或甲基二取代的3'-磺酰基 - 苯基取代基,在2位是亚氨基,在1位是脂族基 或脂环族取代基。 所述噻唑烷具有利尿活性。

    2-Aminomethyl-6-sulfamoylphenol derivatives with salidiuretic activities
    6.
    发明授权
    2-Aminomethyl-6-sulfamoylphenol derivatives with salidiuretic activities 失效
    2-氨基甲基-6-磺酰基苯酚衍生物,具有耐盐水活性

    公开(公告)号:US4766241A

    公开(公告)日:1988-08-23

    申请号:US102793

    申请日:1987-09-23

    CPC classification number: C07D295/26 C07C309/00

    Abstract: The invention relates to 2-aminomethylphenols of the formula I ##STR1## in which R.sup.1 and R.sup.2 represent hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl or benzyl which is optionally substituted by alkyl, alkoxy or halogen, R.sup.3 and R.sup.5 denote hydrogen, halogen, alkyl or alkoxy, R.sup.4 denotes halogen, alkyl or cycloalkyl and R.sup.6 and R.sup.7 represent hydrogen or alkyl, it being possible for the radicals R.sup.1 and R.sup.2, R.sup.6 R.sup.7 and/or two of the radicals R.sup.3, R.sup.4 and R.sup.5 to form an alkylene chain which is optionally substituted by methyl groups and which, in the case of the radicals R.sup.1, R.sup.2, R.sup.6 and R.sup.7, can also be interrupted by oxygen atoms, sulfur atoms and/or imino groups, and to physiologically acceptable salts thereof, a process for their preparation, and their use and to pharmaceutical formulations based on these compounds.

    Abstract translation: 本发明涉及式I的2-氨基甲基苯酚,其中R 1和R 2表示氢,烷基,烯基,炔基,环烷基或苄基,其任选被烷基,烷氧基或卤素取代,R 3和R 5表示氢,卤素, 烷基或烷氧基,R 4表示卤素,烷基或环烷基,R 6和R 7表示氢或烷基,基团R 1和R 2,R 6 R 7和/或基团R 3,R 4和R 5中的两个可以形成亚烷基链, 任选被甲基取代,并且在基团R 1,R 2,R 6和R 7的情况下,也可以被氧原子,硫原子和/或亚氨基基团及其生理上可接受的盐中断, 制剂及其用途以及基于这些化合物的药物制剂。

Patent Agency Ranking